GLYCO-3P

Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination

Empagliflozin+Linagliptin+MetforminOngoingRecruitingPhase 4Open NCT06862739 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…